6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party-Reference-Cited by-同舟云学术

6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party

Published:2006 Issue:1 Volume:73 Page:25-31
ISSN:0012-2823
Container-title:Digestion
language:en
Short-container-title:Digestion

Author:

de Boer N.K.H.,Reinisch W.,Teml A.,van Bodegraven A.A.,Schwab M.,Lukas M.,Ochsenkühn T.,Petritsch W.,Knoflach P.,Almer S.,van der Merwe S.W.,Herrlinger K.R.,Seiderer J.,Vogelsang H.,Mulder C.J.J.

Publisher

S. Karger AG

Subject

Gastroenterology

Reference48 articles.

1. Guidelines for the management of inflammatory bowel disease in adults

2. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease

3. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

4. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease

5. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease;Frontiers in Microbiology;2023-02-23

2. Clinical Management of Herpes Simplex Virus Keratitis;Diagnostics;2022-09-29

3. 6-Thioguanine Inhibits Herpes Simplex Virus 1 Infection of Eyes;Microbiology Spectrum;2021-12-22

4. Stability and Beyond-Use Date of a Compounded Thioguanine Suspension;Journal of Pharmacy Technology;2020-10-13

5. A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patients;Alimentary Pharmacology & Therapeutics;2020-04-27